InspireMD Inc.

InspireMD Inc.
Stock Exchange NYSE
EPS
$16.73
Market Cap
$4.93 M
Shares Outstanding
1.4 M
Public Float
37.08 M

Profile

Address
4 Menorat Hamaor Street
Tel Aviv TA 67448
Israel
Employees -
Website http://www.inspiremd.com
Updated 07/08/2019
InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.

Financials

View All
Created with Highcharts 5.0.14InspireMD Inc.Net Income. Fiscal year is January-December. All values USD Thousands.29 25829 25825 09525 09515 58515 5858 4618 4618 4388 4387 2407 24020132014201520162017201805k10k15k20k25k30k35k
Created with Highcharts 5.0.14InspireMD Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.4 8734 8732 8182 8182 3102 3101 8941 8942 7612 7613 6013 60120132014201520162017201801k2k3k4k5k6k

James J. Barry
President, Chief Executive Officer & Director
Paul S. Stuka
Chairman